The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: A randomized controlled trial

Title
The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: A randomized controlled trial
Authors
Keywords
Schizophrenia, Antipsychotic, Treatment, Polypharmacy, Monotherapy, Switch, Clinical trial, Randomized
Journal
SCHIZOPHRENIA RESEARCH
Volume 166, Issue 1-3, Pages 194-200
Publisher
Elsevier BV
Online
2015-07-03
DOI
10.1016/j.schres.2015.05.038

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation